Corcept Therapeutics (CORT) Stock News
$CORT · NASDAQ · 2 stories in 30 daysBORSA has published 2 stories on Corcept Therapeutics (CORT) in the past 30 days. CORT last closed at $121.19 on Oct 12, down 0.69% over five sessions and up 7.45% over the past month. Corcept Therapeutics’ next earnings report is scheduled for Tuesday, Nov 3.
The wire on $CORT
newest first · updated · direct subject stories onlyCorcept Therapeutics names Justin Gunn to succeed Maduck as endocrinology division president from Oct 1
Justin Gunn will succeed Sean Maduck as president of Corcept's endocrinology division, effective Oct 1. Maduck is retiring.
neutral 50 · impact 10Corcept Therapeutics president of endocrinology Sean Maduck to retire
Sean Maduck, President of Corcept Therapeutics' Endocrinology Division, is retiring.
neutral 50 · impact 30The wire on this name is open. What the tape did about it is one free account away.
One free account opens every story complete, the live board and the 30-day calendar, and 3 complete ticker and report views a day. No card. The wire stays free to read.
BORSAPLUSNews on Price · Earnings read · Flow and ownership · Options context
Create a free account · no card